At The Center for Liver & Metabolic Health, our mission is to deliver exceptional, evidence-based care for patients with liver and metabolic diseases while advancing the future of medicine through innovation and clinical research.
We are committed to:
At Texas Clinical Research Institute (TCRI), we combine scientific excellence, clinical expertise, and an unwavering commitment to ethical research. As an independent clinical research center, we provide sponsors, CROs, and participants with a highly experienced and efficient research environment focused on quality, integrity, and results.
At TCRI, experience, integrity, and excellence are at the center of everything we do.
At Texas Clinical Research Institute (TCRI), we have developed a modern clinical research facility specifically designed to support efficient, high-quality Phase I–IV clinical trials. Our infrastructure is built to provide sponsors, CROs, research monitors, and study participants with an exceptional research environment while maintaining the highest standards of quality, regulatory compliance, and patient safety.
Our center offers dedicated research space designed exclusively for clinical trial operations, including:
* Multiple fully equipped examination rooms
* Comfortable examination beds suitable for pharmacokinetic (PK) studies and extended participant observation
* Private full bathrooms designed to accommodate overnight study participants
* Dedicated medication storage room with an independent temperature-controlled HVAC system
* Secure investigational product storage with continuous temperature monitoring
* Laboratory equipped for immediate specimen processing
* Refrigerators, freezers, and centrifuges for study sample handling and storage
* Backup electrical generator to protect critical research equipment and investigational products during power interruptions
We believe that informed patients make better health decisions. Our education center provides clear, reliable information about:
Our resources are designed to help you:
Understand your diagnosis
Learn about treatment options
Take an active role in your health
Through our partnership with Texas Clinical Research Institute
Our patients have access to cutting-edge clinical trials evaluating the latest therapies in:
Fatty liver disease (MASH)
Alcohol-associated liver
Cirrhosis
Hepatitis C
primary Biliary Cholangiti
Inflammatory Bowel Disease
Obesity
Studies for patients with fatty liver disease diagnosed on imaging or suspected based on liver enzymes.
Studies for patients with cirrhosis secondary to metabolic disorder diagnosed or suspected due to lab patterns.
Study for patients with chronic alcohol heavy alcohol use (≥ 50Gm/day) > 5 years with fatty liver disease.
Study for patients with a diagnosis of noncirrhotic NASH with liver fibrosis (Fibrosis stage F1-F3) confirmed by liver biopsy.
Definite or probable PBC
Patients with symptoms despite being on therapy or having received treatment in the past
This integration of clinical care and research allows us to provide treatment options that go beyond standard therapy.
Our team is led by experienced specialists in hepatology and gastroenterology who are nationally recognized for their expertise in gastrointestinal, liver disease and clinical research.
Hepatology and Gastroenterology
Medical Director
Principal investigator/ Sub- investigator
Research Manager
Research Manager
